Role of the <i>CDKN2A</i> Locus in Patients With Multiple Primary Melanomas

Abstract

MPM patients are good candidates for CDKN2A mutational screening. These patients and some of their siblings should be included in a program of specific follow-up with total body photography and digital dermoscopy, which will result in the early detection of melanoma in this subset of high-risk patients and improve phenotypic characterization.